Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for Neuroone Medical Technologies (NMTC) over the last 9 years, with Q4 2025 value amounting to -$439992.0.

  • Neuroone Medical Technologies' Change in Account Payables fell 284525.74% to -$439992.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$185070.0, marking a year-over-year decrease of 57364.32%. This contributed to the annual value of $239983.0 for FY2025, which is 25822.1% up from last year.
  • Per Neuroone Medical Technologies' latest filing, its Change in Account Payables stood at -$439992.0 for Q4 2025, which was down 284525.74% from $526943.0 recorded in Q3 2025.
  • Over the past 5 years, Neuroone Medical Technologies' Change in Account Payables peaked at $602635.0 during Q3 2022, and registered a low of -$439992.0 during Q4 2025.
  • Its 5-year average for Change in Account Payables is $1396.8, with a median of -$18435.0 in 2021.
  • Over the last 5 years, Neuroone Medical Technologies' Change in Account Payables had its largest YoY gain of 374627.09% in 2025, and its largest YoY loss of 284525.74% in 2025.
  • Over the past 5 years, Neuroone Medical Technologies' Change in Account Payables (Quarter) stood at $291172.0 in 2021, then crashed by 152.92% to -$154098.0 in 2022, then surged by 151.61% to $79527.0 in 2023, then tumbled by 118.78% to -$14939.0 in 2024, then plummeted by 2845.26% to -$439992.0 in 2025.
  • Its last three reported values are -$439992.0 in Q4 2025, $526943.0 for Q3 2025, and -$367845.0 during Q2 2025.